The outlook revision is based on a number of factors, including Moody’s Investors Service’s expectation that AHS will continue to maintain strong operating performance and will improve balance sheet metrics.
Moody’s also assigned an “A1” rating to AHS’ proposed series 2016 revenue refunding bonds, affecting $225.7 million. The rating affirmation reflects AHS’ favorable market position, strong revenue growth and maintenance of balance sheet metrics.
More articles on healthcare finance:
Accipiter Capital ups stake in CHS
Zika babies cost up to $10M in healthcare spending
4 hospital CFOs in the headlines
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.